Stifel Financial
AVDL

Stifel Financial’s Avadel Pharmaceuticals AVDL Stock Holding History

Stifel Financial’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,972
Closed -$288K – 3386
2024
Q3 		$288K Sell
21,972
-1,452
-6% -$22.1K ﹤0.01% 2983
2024
Q2 		$329K Sell
23,424
-1,452
-6% -$23.7K ﹤0.01% 2866
2024
Q1 		$420K Buy
+24,876
New +$370K ﹤0.01% 2720
2017
Q4 		– Sell
-64,500
Closed -$677K – 2655
2017
Q3 		$677K Buy
64,500
+4,000
+7% +$38.2K ﹤0.01% 1711
2017
Q2 		$667K Buy
60,500
+2,500
+4% +$25.1K ﹤0.01% 1711
2017
Q1 		$561K Hold
58,000
– – ﹤0.01% 1753
2016
Q4 		$603K Buy
58,000
+2,000
+4% +$22K ﹤0.01% 1677
2016
Q3 		$694K Buy
56,000
+7,000
+14% +$91.5K ﹤0.01% 1527
2016
Q2 		$1.19M Buy
49,000
+5,000
+11% +$53.3K 0.01% 1245
2016
Q1 		$486K Buy
44,000
+10,750
+32% +$107K ﹤0.01% 1595
2015
Q4 		$406K Hold
33,250
– – ﹤0.01% 1772
2015
Q3 		$542K Buy
33,250
+3,000
+10% +$66.1K ﹤0.01% 1505
2015
Q2 		$641K Buy
30,250
+4,250
+16% +$76.2K ﹤0.01% 1558
2015
Q1 		$467K Sell
26,000
-2,980
-10% -$46.7K ﹤0.01% 1659
2014
Q4 		$496K Buy
28,980
+2,895
+11% +$41.3K ﹤0.01% 1615
2014
Q3 		$373K Buy
26,085
+85
+0.3% +$1.22K ﹤0.01% 1686
2014
Q2 		$390K Buy
26,000
+10,000
+63% +$121K ﹤0.01% 1638
2014
Q1 		$214K Buy
+16,000
New +$171K ﹤0.01% 1891

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Stifel Financial's AVDL Position: Q4 2024 in Review

Stifel Financial sold out of Avadel Pharmaceuticals (AVDL) in Q4 2024, closing a stake of 21,972 shares — an estimated $288K sold.

Stifel Financial first reported a position in AVDL in Q1 2014 and held it in 18 quarters. The position peaked at $1.19M in Q2 2016. 159 funds tracked by Wall St. Rank hold AVDL as of Q4 2024.

  • Stifel Financial reported no remaining Avadel Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Stifel Financial sold 21,972 Avadel Pharmaceuticals shares in Q4 2024, an estimated $288K.
  • Stifel Financial first reported a position in Avadel Pharmaceuticals in Q1 2014 and held it in 18 quarters.
  • Stifel Financial's Avadel Pharmaceuticals position peaked at $1.19M in Q2 2016.
  • 159 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2024.

Based on Stifel Financial's 13F filing for Q4 2024, filed 13 Feb 2025.